Yubo International Biotech is a small Chinese health and wellness company that sells consumer health and personal care products under its VIVCELL brand through its Chinese operating entity, Yubo Beijing. VIVCELL products are marketed as stem cell-derived or growth factor-based formulations across several categories, including respiratory treatments, skincare, eye care, hair care, and personal hygiene products. These products target middle- and high-income consumers in China with specific health concerns. Yubo Beijing sells through a direct sales and franchise model, operating "biological experience center stores" that function as both retail points of sale and brand showrooms. The company outsources manufacturing to third-party contract manufacturers. Beyond consumer products, Yubo Beijing offers cell testing and health management consulting services, though these are a minor part of the business. The company's longer-term ambition is to build an endometrial stem cell repository to supply biological material for its product lines, but this facility is not yet operational. Currently, only the consumer product business generates revenue, and that revenue is entirely concentrated in a single customer. Yubo Beijing employs just 14 people. U.S. investors hold no direct equity in Yubo Beijing; control is exercised through contractual VIE arrangements, which carry standard but material risks, including potential non-compliance findings by Chinese regulators and limited enforceability of U.S. securities law against management.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →